Gaudium IVF holds 11th AGM on Sep 28, 2026, transacting all businesses
Gaudium IVF held its 11th AGM on Sep 28, 2026, transacting all businesses. Key agenda items included adopting FY26 financial statements and approving director re-appointments and remuneration. The meeting highlighted the company's listing, financial performance, and strategic growth initiatives.
The announcement pertains to the proceedings of an Annual General Meeting, which is a regular corporate event. It does not introduce any new material information that would significantly impact the company's financials, operations, or stock price.
The announcement is a routine update on the proceedings of the Annual General Meeting, which is a standard corporate event. It details the businesses transacted and does not contain any new financial information or strategic decisions that would alter the company's outlook.
Gaudium IVF and Women Health Limited conducted its 11th Annual General Meeting (AGM) on Monday, September 28, 2026, from 02:00 P.M. IST to 03:13 P.M. IST through Video Conferencing (VC)/Other Audio-Visual Means (OAVM), facilitated by NSDL. All businesses as outlined in the AGM Notice dated September 03, 2026, were transacted during the meeting.
The meeting commenced with a welcome address by the Moderator and Company Secretary, Naveen Kumar, who explained the VC/OAVM proceedings and the role of NSDL. The Annual Report and Notice of AGM, sent electronically to registered members, were taken as read. The remote e-voting period was from September 25 to September 27, 2026, with a cut-off date of September 21, 2026, for determining voting rights.
Key management personnel, including Chairperson and Managing Director Dr. Manika Khanna, Whole-Time Director Dr. Peeyush Khanna, and CFO Rakesh Kumar Sharma, were present. The meeting covered ordinary businesses such as the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026, and the re-appointment of director Mr. Vishad Khanna. Special businesses included the approval of revised remuneration for Dr. Peeyush Khanna and ratification of remuneration for Dr. Manika Khanna. The appointment of M/s. Suresh Nainwal & Company as Secretarial Auditors for five years was also proposed.
During the Q&A session, queries from members were addressed by the Chairperson and CFO. The Chairperson highlighted the company's listing on NSE and BSE on February 27, 2026, its transition to a listed healthcare platform, financial performance for FY2025-26, growth in revenue and EBITDA, and strategic priorities including AI-enabled tools and international expansion.
The Company Secretary confirmed that the Statutory Auditors' Reports and Secretarial Audit Report were free from qualifications. The results of the voting, along with the Scrutinizer's Report, will be submitted to the stock exchanges and hosted on the company's website within two working days. The recorded transcript of the meeting will also be made available online.
What to do with a filing like this
Gaudium IVF and Women Health Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gaudium IVF and Women Health Limited. Read the original for the full detail.